In an environment defined by rapid scientific advancement, complex funding cycles, and evolving market dynamics, securing expert guidance is critical.
We partner with universities, research institutions, VC funds, biotech companies, and corporates to unlock the value of scientific discovery and accelerate translation.
We provide the specialised insights, strategic counsel, and execution support necessary to achieve success in the global health and biotech ecosystem.
Tech Transfer Strategy
We design tailored institutional strategies to improve spinout creation and success
Technology Evaluation
We assess the technical and commercial potential, and competitive edge of early-stage innovation to guide decision making
Ecosystem Access
We connect our partners to Cambridge’s premier life sciences innovation and talent network
Opportunity Scouting
We uncover promising research and ventures that offer strategic opportunities for companies, investors and accelerators
We design tailored institutional strategies to improve spinout creation and success
Press release
Cambridge Biocapital Launches to Spearhead European Health Technology Transfer with Landmark €1.3M EIT Health ‘Healthpreneurs’ Consortium
June 9, 2025